Systemic scleroderma
Not recruitingA study to test if tibulizumab works and is safe for adults with systemic sclerosis
- Disease:Systemic scleroderma
- Substances:–
Hungary- Participants:18–64 years · 65+ years
- Sponsor:Zura Bio Inc.
Rare diseases
Investigational molecules
Locations
1489 West Warm Springs Road, 89014-7635, United States
Clinical research in hidradenitis suppurativa focuses on reducing inflammatory lesions and improving disease control in adults living with chronic, recurrent skin involvement. The sponsor’s work in this area centers on therapeutic evaluation for a condition marked by painful nodules, abscesses, and scarring.
These studies reflect interest in treatment options for persistent cutaneous inflammation and the clinical burden associated with localized skin disease.
Zura Bio Inc. runs clinical trials in conditions such as Systemic scleroderma, Hidradenitis, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Hungary
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.